Filing Details
- Accession Number:
- 0000913849-17-000035
- Form Type:
- 13G Filing
- Publication Date:
- 2017-02-10 16:25:34
- Filed By:
- Cvf, Llc
- Company:
- Dare Bioscience Inc. (NASDAQ:DARE)
- Filing Date:
- 2017-02-10
- SEC Url:
- 13G Filing
Ownership Summary
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| CVF | 2,601,387 | 7. | 2,601,387 | 9. | 2,601,387 | 9.48% |
Filing
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 2)*
| Cerulean Pharma Inc. |
| (Name of Issuer) |
| Common Stock, $0.0001 par value per share |
| (Title of Class of Securities) |
| 15708Q105 |
| (CUSIP Number) |
| December 31, 2016 |
| (Date of Event Which Requires Filing of this Statement) |
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
☐ Rule 13d-1(b)
☐ Rule 13d-1(c)
ý Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
| 1. | NAME OF REPORTING PERSON CVF, LLC | |||
| 2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP | (a) ☐ (b) ☐ | ||
| 3. | SEC USE ONLY | |||
| 4. | CITIZENSHIP OR PLACE OF ORGANIZATION Delaware | |||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: | 5. | SOLE VOTING POWER 2,601,387 | ||
| 6. | SHARED VOTING POWER — | |||
| 7. | SOLE DISPOSITIVE POWER 2,601,387 | |||
| 8. | SHARED DISPOSITIVE POWER — | |||
| 9. | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,601,387 | |||
| 10. | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐ | |||
| 11. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.48% | |||
| 12. | TYPE OF REPORTING PERSON OO | |||
| Item 1(a). | Name of Issuer: | |
| Cerulean Pharma Inc. | ||
| Item 1(b). | Address of Issuer’s Principal Executive Offices: | |
| 840 Memorial Drive, Cambridge, Massachusetts 02139 | ||
| Item 2(a). | Name of Person Filing: | |
| CVF, LLC (“CVF”) | ||
| Item 2(b). | Address of Principal Business Office or, if none, Residence: | |
| 222 N. LaSalle Street, Suite 2000, Chicago, Illinois 60601 | ||
| Item 2(c). | Citizenship: | |
| Delaware | ||
| Item 2(d). | Title of Class of Securities: | |
| Common Stock, $0.0001 par value per share | ||
| Item 2(e). | CUSIP Number: | |
| 15708Q105 | ||
| Item 3. | If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), indicate type of person filing. Not applicable. | |
| Item 4. | Ownership. | |
| (a) | Amount beneficially owned: See row 9 of the cover page. | |
| (b) | Percent of class: See row 11 of the cover page. | |
| (c) | Number of shares as to which such person has: | |
| (i) Sole power to vote or direct the vote: See row 5 of the cover page. | ||
| (ii) Shared power to vote or direct the vote: See row 6 of the cover page. | ||
| (iii) Sole power to dispose or to direct the disposition of: See row 7 of the cover page. | ||
| (iv) Shared power to dispose or to direct the disposition of: See row 8 of the cover page. | ||
| CUSIP No. 15708Q105 | 13G | Page 4 of 5 Pages |
| Percent of class is based on (i) the number of shares held by CVF as of December 31, 2016 and (ii) the number of shares of common stock outstanding as of October 31, 2016 (27,435,680 shares) as reported by the Issuer in its most recent Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 3, 2016. | |
| Item 5. | Ownership of Five Percent or Less of a Class. |
| Not applicable. | |
| Item 6. | Ownership of More than Five Percent on Behalf of Another Person. |
| Not applicable. | |
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. |
| Not applicable. | |
| Item 8. | Identification and Classification of Members of the Group. |
| Not applicable. | |
| Item 9. | Notice of Dissolution of Group. |
| Not applicable. | |
| Item 10. | Certifications. |
| Not applicable. | |